- Home
- PSBD vs KOD Comparison
PSBD vs KOD Comparison
Compare PSBD & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSBD
- KOD
- Stock Information
- Founded
- PSBD 2009
- KOD 2009
- Country
- PSBD United States
- KOD United States
- Employees
- PSBD N/A
- KOD N/A
- Industry
- PSBD
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PSBD
- KOD Health Care
- Exchange
- PSBD Nasdaq
- KOD Nasdaq
- Market Cap
- PSBD 519.7M
- KOD 454.7M
- IPO Year
- PSBD 2024
- KOD 2018
- Fundamental
- Price
- PSBD $15.80
- KOD $7.17
- Analyst Decision
- PSBD Buy
- KOD Hold
- Analyst Count
- PSBD 7
- KOD 4
- Target Price
- PSBD $16.93
- KOD $8.00
- AVG Volume (30 Days)
- PSBD 17.7K
- KOD 464.9K
- Earning Date
- PSBD 02-08-2025
- KOD 11-14-2024
- Dividend Yield
- PSBD 12.02%
- KOD N/A
- EPS Growth
- PSBD N/A
- KOD N/A
- EPS
- PSBD N/A
- KOD N/A
- Revenue
- PSBD N/A
- KOD N/A
- Revenue This Year
- PSBD N/A
- KOD N/A
- Revenue Next Year
- PSBD N/A
- KOD N/A
- P/E Ratio
- PSBD N/A
- KOD N/A
- Revenue Growth
- PSBD N/A
- KOD N/A
- 52 Week Low
- PSBD $15.12
- KOD $2.19
- 52 Week High
- PSBD $17.12
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- PSBD 54.56
- KOD 42.02
- Support Level
- PSBD $15.17
- KOD $7.21
- Resistance Level
- PSBD $16.07
- KOD $9.14
- Average True Range (ATR)
- PSBD 0.41
- KOD 0.89
- MACD
- PSBD 0.05
- KOD -0.35
- Stochastic Oscillator
- PSBD 71.58
- KOD 0.27
About PSBD Palmer Square Capital BDC Inc.
Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.